logo
Plus   Neg
Share
Email

Eli Lilly: FDA Grants Fast Track Designation To Empagliflozin - Quick Facts

Boehringer Ingelheim and Eli Lilly and Company (LLY) said the FDA has granted Fast Track designation to empagliflozin for the ongoing EMPEROR program, which will evaluate the effect of the tablet on cardiovascular death and hospitalization for heart failure in adults with chronic heart failure with reduced or preserved ejection fraction. The EMPEROR phase III studies are part of the empagliflozin chronic heart failure program.

Empagliflozin is marketed as Jardiance in the U.S. Jardiance is a registered trademark of Boehringer Ingelheim.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Target Corp. (TGT) announced a retail collaboration with Walt Disney Co. (DIS) that will open 25 Disney stores within select Target stores nationwide on October 4, with 40 additional locations opening by October 2020. Target will also open a store at Flamingo Crossings Town Center at the western entrance of the Walt Disney World Resort in 2021. Whole Foods Market stores have recalled Decorated Red Apple Cookies as they may contain undeclared egg. People who have an allergy or severe sensitivity to these allergens run the risk of serious or life-threatening allergic reaction if they consume these products. The cookies were sold by the... Norwex has announced voluntary recall of about 58,000 rubber brooms due to laceration hazard. According to the company, handles of the recalled brooms can break in half, exposing a metal inner rim, posing a laceration hazard to the user. The recall involves extendable indoor/outdoor white rubber...
Follow RTT